Medicare Enrolled

Dr. Ilya Burshteyn, MD

Dermatology · Forest Hills, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10525 64TH AVE, Forest Hills, NY 11375
7184593494
In practice since 2006 (20 years)
NPI: 1073546131 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burshteyn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burshteyn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burshteyn

Dr. Ilya Burshteyn is a dermatology specialist in Forest Hills, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Burshteyn performed 4,481 Medicare services across 1,594 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burshteyn received a total of $4,931 from 37 pharmaceutical and/or device companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burshteyn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in NY $4,931 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,481
Medicare services
Top 5% in NY for dermatology
1,594
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~224 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
992 $51 $70
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
659 $81 $120
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
577 $81 $140
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
343 $52 $140
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
338 $5 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
326 $113 $160
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
273 $61 $100
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
160 $100 $140
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
155 $35 $100
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
145 $13 $30
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
144 $13 $40
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
75 $1 $10
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
62 $83 $120
Injection, thiamine hcl, 100 mg 53 $2 $10
Pyridoxine HCl injection, 100 mg
An injection of pyridoxine hydrochloride, a form of vitamin B6, administered at a dose of 100 mg.
52 $7 $10
Home health plan of care re-certification
A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present.
41 $36 $48
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
37 $0 $5
Stool test for hidden blood (FIT)
A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method.
20 $16 $40
Influenza vaccine, quadrivalent, 0.5 ml dosage 15 $20 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $123 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.1% high complexity
8.1% medium
85.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,931
Total received (2018-2024)
Avg $704/year across 7 years
Top 8% in NY for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,907 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$804
2023
$776
2022
$729
2021
$714
2020
$771
2019
$629
2018
$508

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$438
Lilly USA, LLC
$77
AIMMUNE THERAPEUTICS, INC.
$77
Otsuka America Pharmaceutical, Inc.
$70
Amgen Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
Novo Nordisk Inc
$22
Corcept Therapeutics
$19
Top 3 companies account for 73.7% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$583
Lilly USA, LLC
$517
ABBVIE INC.
$478
AbbVie Inc.
$413
Boehringer Ingelheim Pharmaceuticals, Inc.
$351
Merck Sharp & Dohme Corporation
$303
AstraZeneca Pharmaceuticals LP
$237
Amarin Pharma Inc.
$186
NESTLE HEALTHCARE NUTRITION INC.
$179
Astellas Pharma US Inc
$133
Ardelyx, Inc.
$129
Amgen Inc.
$126
Kowa Pharmaceuticals America, Inc.
$103
Nestle HealthCare Nutrition Inc.
$102
AbbVie, Inc.
$97
Allergan, Inc.
$91
Scilex Pharmaceuticals Inc.
$87
Ironwood Pharmaceuticals, Inc
$79
AIMMUNE THERAPEUTICS, INC.
$77
Merck Sharp & Dohme LLC
$74
RedHill Biopharma Inc.
$72
Otsuka America Pharmaceutical, Inc.
$70
PFIZER INC.
$65
Sunovion Pharmaceuticals Inc.
$48
Novo Nordisk Inc
$46
VIVUS LLC
$39
GENZYME CORPORATION
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Novartis Pharmaceuticals Corporation
$25
SCILEX PHARMACEUTICALS INC.
$23
Xeris Pharmaceuticals, Inc.
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
Daiichi Sankyo Inc.
$21
Corcept Therapeutics
$19
IBSA Pharma Inc.
$17
Allergan Inc.
$16
GlaxoSmithKline, LLC.
$15
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
Aimovig · BELSOMRA · CAPLYTA · CERDELGA · COLOGUARD · CREON · Creon · DUEXIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · GEMTESA · GVOKE HYPOPEN · IBSRELA · JANUVIA · JARDIANCE · Korlym · LINZESS · LYRICA · Licart · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Movantik · Myrbetriq · Otezla · Ozempic · PENNSAID · Pancreaze · QULIPTA · REXULTI · Rybelsus · SEGLENTIS · SPIRIVA RESPIMAT · STEGLATRO · Seglentis · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VIBERZI · VIMOVO · VOWST · VRAYLAR · Vascepa · Welchol · XIFAXAN · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for dermatology in NY.

Looking for a dermatology specialist in Forest Hills?
Compare dermatologists in the Forest Hills area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
581
Per 100K population
24.9
County median income
$84,961
Nearest hospital
JAMAICA HOSPITAL MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Burshteyn is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement in the top 8% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Burshteyn experienced with office visit, established patient (10-19 min)?
Based on Medicare claims data, Dr. Burshteyn performed 992 office visit, established patient (10-19 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burshteyn receive payments from pharmaceutical companies?
Yes. Dr. Burshteyn received a total of $4,931 from 37 companies across 254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burshteyn's costs compare to other dermatologists in Forest Hills?
Dr. Burshteyn's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burshteyn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →